---
schema_version: "secwatch.filing_event.v1"
accession: "0001367644-24-000134"
form_type: "8-K"
ticker: "EBS"
cik: "0001367644"
company_name: "Emergent BioSolutions Inc."
filed_at: "2024-07-31T23:59:59+00:00"
generated_at: "2026-05-31T14:18:47.496284+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Emergent BioSolutions sells RSDL decontamination kit to SERB for $75M

## Summary
- Cash purchase price of $75M at closing; additional $5M milestone payment for component sourcing.
- Sale includes Hattiesburg, MS manufacturing facility, IP, inventory, and marketing authorizations; employees to join SERB.
- Emergent's Winnipeg facility will manufacture bulk lotion for SERB under long-term supply agreement.
- SERB assumes existing RSDL supply contract with U.S. Department of Defense.
- Net proceeds expected to reduce debt by >$150M, targeting elimination of Junior Capital Raise requirement.

## SEC filing metadata
- accession: 0001367644-24-000134
- form_type: 8-K
- ticker: EBS
- cik: 0001367644
- company_name: Emergent BioSolutions Inc.
- filed_at: 2024-07-31T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367644/000136764424000134/0001367644-24-000134-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367644/000136764424000134/ebs-20240731.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001367644-24-000134
- JSON: https://secwatch.observer/filing/0001367644-24-000134.json
- Plain text: https://secwatch.observer/filing/0001367644-24-000134.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.